Prevalence of extended-spectrum β-lactamases in nosocomial and outpatients (ambulatory)

Pakistan Journal of Medical Sciences

Volumn 19, Issue 3, 2003, Pages 187-191

  Shah, Aamer Ali ^a   Hasan, Fariha ^a   Ahmed, Safia ^a   Hameed, Abdul ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Extended spectrum lactamases; Klebsiella pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; OUTPATIENT; PERITONEAL FLUID; PLEURA FLUID; POSTOPERATIVE PERIOD; PREVALENCE; PUS; SPUTUM ANALYSIS; STRAIN DIFFERENCE; URINALYSIS;

EID: 0141670724     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Quintiani R & Courvalin P. Mechanism of resistance to antibiotics. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, Eds. Manual of clinical microbiology 6th ed, Washington DC. ASM Press. 1995; 1368-1326.
2. Gold HS & Moellering RC Jr. Antimicrobial Drug Resistance. N Eng J Med 1996;335(19):1445-1452.
3. Thomson KS, Prevan AM & Sanders CC. β-lactamases in Enterobacteriaceae: Emerging problem for new β-lactam antibiotics. Curr Clin Top Infect Dis 1996;16:151-163.
4. Jarlier V, Nicolas MH, Fournier G & Philippon A. Extended-spectrum B-lactamases conferring transferable resistance to newer B-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-878.
5. Chanal C, Sirot D, Romaszko JP, Bret L & Sirot J. Survey of the prevalence of extended-spectrum β-lactamase among Enterobacteriaceae. J Antimicrob Chemother 1996;38:127-132.
6. Philippon A. Labia R. & Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989;33:1131-1136.
7. Lucet JC, Chevret S, Vanjak D, Decre D, Macrez A & Wolff M. Outbreak of multiple resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430-436.
8. Machka K, Braveny I, Dabernat H, Dornsbusch K, Kayser FH & Klingeren BV. Distribution and resistance pattern of haemophilus influenzae: A European collaborative study. Eur J Clin Microbiol Infect Dis. 1988;7:14-24.
9. Jonson AP & Woodford N. Bacterial antibiotic resistance. Curr Opin Infect Dis 1993;6:515-519.
10. Jacoby GA. Extended-spectrum β-lactamase and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875-887.
11. Schiappa DA, Hayden MK & Matushek MG. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation. J Infect Dis 1996;174:529-536.
12. Meyer KS, Urban C, Eagan JA, Berger BJ & Rahal JJ. Nosocomial outbreak of klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-358.
13. Gaillot O, maruejouls C & Abachin E. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357-1360.
14. Spencer RC, Wheet PF, Wisntanley TG, Cox DM & Plested SJ. Novel B-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to β-lactam antibiotics. J Antimicrob Chemother 1987;200:919-921.
15. Blahova J, Kralikova K & Krcmery V. New aspects of antibiotic resistance and possibilities of its prevention. Cas Lek Cesk 2001;140(16):487-491.
16. Patterson JE, Extended-spectrum β-lactamases. Semin Respir Infect 2000;15(4):299-307.
17. Liassine N. Problems of antibiotic-resistance Gram negative pathogens in the hospital environment. Schweiz Med Wochenschr 2000;130(50):1930-1936.